Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
40.02%Return on Equity
VS
Market
Sector
Industry
History
$ 3.74Close
$ 0.43 - $ 3.74 52-Week Range
Ticker Information
Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCYTOMX THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CTMX - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 119.91M | $ 47.98M | 40.02% |
| 3/31/2025 | $ 25.05M | $ 41.6M | 166.09% |
| 12/31/2024 | $ -456K | $ 31.87M | 0% |
| 9/30/2024 | $ -23.45M | $ 13.83M | 0% |
| 6/30/2024 | $ -31.23M | $ 11.09M | 0% |
| 3/31/2024 | $ -31.68M | $ 16.53M | 0% |
| 12/31/2023 | $ -47.45M | $ -569K | 0% |
| 9/30/2023 | $ -51.24M | $ -29.36M | 0% |
| 6/30/2023 | $ -85.03M | $ -55.65M | 0% |
| 3/31/2023 | $ -86.64M | $ -78.74M | 0% |
Key Performance Insights, Last 5 Years
- CYTOMX THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -111.6%.
- Over the past 5 years, CYTOMX THERAPEUTICS INC's average ROE has been -81.51%.
- The median ROE for CYTOMX THERAPEUTICS INC during this period was -66.03%
- CYTOMX THERAPEUTICS INC reached its highest ROE over the past 5 years at 166.09%.
- The lowest ROE recorded by CYTOMX THERAPEUTICS INC in the same timeframe -342.74%
CYTOMX THERAPEUTICS INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for CYTOMX THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -53.64M ] / Equity [ $ 48.06M ]
(=) ROE [ -111.6% ] CTMX - Return on Equity, Last 5 years
-342.74%
Minimum
Sep 30, 2022
166.09%
Maximum
Mar 31, 2025
-81.51%
Average
-66.03%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |